Copyright Reports & Markets. All rights reserved.

Global Antihypertensive Market Research Report 2019

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Antihypertensive Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Antihypertensive Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Antihypertensive Market Size Growth Rate by Type
    • 1.4.2 Diuretics
    • 1.4.3 Angiotensin receptorblockers (ARBs)
    • 1.4.4 Angiotensin converting enzyme (ACE) inhibitors
    • 1.4.5 Beta blockers
    • 1.4.6 Alpha blockers
    • 1.4.7 Calcium channel blockers
    • 1.4.8 Renin inhibitors
    • 1.4.9 Vasodilators
  • 1.5 Market by Application
    • 1.5.1 Global Antihypertensive Market Size Growth Rate by Application
    • 1.5.2 Hosptial
    • 1.5.3 Clinic
    • 1.5.4 Home
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Antihypertensive Market Size, Estimates and Forecasts
    • 2.1.1 Global Antihypertensive Revenue 2015-2026
    • 2.1.2 Global Antihypertensive Sales 2015-2026
  • 2.2 Global Antihypertensive, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Antihypertensive Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Antihypertensive Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Antihypertensive Competitor Landscape by Players

  • 3.1 Antihypertensive Sales by Manufacturers
    • 3.1.1 Antihypertensive Sales by Manufacturers (2015-2020)
    • 3.1.2 Antihypertensive Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Antihypertensive Revenue by Manufacturers
    • 3.2.1 Antihypertensive Revenue by Manufacturers (2015-2020)
    • 3.2.2 Antihypertensive Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Antihypertensive Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Antihypertensive Revenue in 2019
    • 3.2.5 Global Antihypertensive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Antihypertensive Price by Manufacturers
  • 3.4 Antihypertensive Manufacturing Base Distribution, Product Types
    • 3.4.1 Antihypertensive Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Antihypertensive Product Type
    • 3.4.3 Date of International Manufacturers Enter into Antihypertensive Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Antihypertensive Market Size by Type (2015-2020)
    • 4.1.1 Global Antihypertensive Sales by Type (2015-2020)
    • 4.1.2 Global Antihypertensive Revenue by Type (2015-2020)
    • 4.1.3 Antihypertensive Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Antihypertensive Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Antihypertensive Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Antihypertensive Revenue Forecast by Type (2021-2026)
    • 4.2.3 Antihypertensive Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Antihypertensive Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Antihypertensive Market Size by Application (2015-2020)
    • 5.1.1 Global Antihypertensive Sales by Application (2015-2020)
    • 5.1.2 Global Antihypertensive Revenue by Application (2015-2020)
    • 5.1.3 Antihypertensive Price by Application (2015-2020)
  • 5.2 Antihypertensive Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Antihypertensive Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Antihypertensive Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Antihypertensive Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Antihypertensive by Country
    • 6.1.1 North America Antihypertensive Sales by Country
    • 6.1.2 North America Antihypertensive Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Antihypertensive Market Facts & Figures by Type
  • 6.3 North America Antihypertensive Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Antihypertensive by Country
    • 7.1.1 Europe Antihypertensive Sales by Country
    • 7.1.2 Europe Antihypertensive Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Antihypertensive Market Facts & Figures by Type
  • 7.3 Europe Antihypertensive Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Antihypertensive by Region
    • 8.1.1 Asia Pacific Antihypertensive Sales by Region
    • 8.1.2 Asia Pacific Antihypertensive Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Antihypertensive Market Facts & Figures by Type
  • 8.3 Asia Pacific Antihypertensive Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Antihypertensive by Country
    • 9.1.1 Latin America Antihypertensive Sales by Country
    • 9.1.2 Latin America Antihypertensive Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Antihypertensive Market Facts & Figures by Type
  • 9.3 Central & South America Antihypertensive Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Antihypertensive by Country
    • 10.1.1 Middle East and Africa Antihypertensive Sales by Country
    • 10.1.2 Middle East and Africa Antihypertensive Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Antihypertensive Market Facts & Figures by Type
  • 10.3 Middle East and Africa Antihypertensive Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Antihypertensive Products Offered
    • 11.1.5 Pfizer Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Antihypertensive Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Description and Business Overview
    • 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi Antihypertensive Products Offered
    • 11.3.5 Sanofi Related Developments
  • 11.4 Merck
    • 11.4.1 Merck Corporation Information
    • 11.4.2 Merck Description and Business Overview
    • 11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Merck Antihypertensive Products Offered
    • 11.4.5 Merck Related Developments
  • 11.5 Boehringer Ingelheim
    • 11.5.1 Boehringer Ingelheim Corporation Information
    • 11.5.2 Boehringer Ingelheim Description and Business Overview
    • 11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Boehringer Ingelheim Antihypertensive Products Offered
    • 11.5.5 Boehringer Ingelheim Related Developments
  • 11.6 Lupin
    • 11.6.1 Lupin Corporation Information
    • 11.6.2 Lupin Description and Business Overview
    • 11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Lupin Antihypertensive Products Offered
    • 11.6.5 Lupin Related Developments
  • 11.7 Johnson & Johnson
    • 11.7.1 Johnson & Johnson Corporation Information
    • 11.7.2 Johnson & Johnson Description and Business Overview
    • 11.7.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Johnson & Johnson Antihypertensive Products Offered
    • 11.7.5 Johnson & Johnson Related Developments
  • 11.8 Astra Zeneca
    • 11.8.1 Astra Zeneca Corporation Information
    • 11.8.2 Astra Zeneca Description and Business Overview
    • 11.8.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Astra Zeneca Antihypertensive Products Offered
    • 11.8.5 Astra Zeneca Related Developments
  • 11.9 Daiichi Sankyo
    • 11.9.1 Daiichi Sankyo Corporation Information
    • 11.9.2 Daiichi Sankyo Description and Business Overview
    • 11.9.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Daiichi Sankyo Antihypertensive Products Offered
    • 11.9.5 Daiichi Sankyo Related Developments
  • 11.10 Ranbaxy
    • 11.10.1 Ranbaxy Corporation Information
    • 11.10.2 Ranbaxy Description and Business Overview
    • 11.10.3 Ranbaxy Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Ranbaxy Antihypertensive Products Offered
    • 11.10.5 Ranbaxy Related Developments
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description and Business Overview
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Antihypertensive Products Offered
    • 11.1.5 Pfizer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Antihypertensive Market Estimates and Projections by Region
    • 12.1.1 Global Antihypertensive Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Antihypertensive Revenue Forecast by Regions 2021-2026
  • 12.2 North America Antihypertensive Market Size Forecast (2021-2026)
    • 12.2.1 North America: Antihypertensive Sales Forecast (2021-2026)
    • 12.2.2 North America: Antihypertensive Revenue Forecast (2021-2026)
    • 12.2.3 North America: Antihypertensive Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Antihypertensive Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Antihypertensive Sales Forecast (2021-2026)
    • 12.3.2 Europe: Antihypertensive Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Antihypertensive Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Antihypertensive Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Antihypertensive Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Antihypertensive Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Antihypertensive Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Antihypertensive Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Antihypertensive Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Antihypertensive Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Antihypertensive Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Antihypertensive Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Antihypertensive Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Antihypertensive Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Antihypertensive Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Antihypertensive Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Antihypertensive Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Antihypertensive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antihypertensive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Antihypertensive market is segmented into
    Diuretics
    Angiotensin receptorblockers (ARBs)
    Angiotensin converting enzyme (ACE) inhibitors
    Beta blockers
    Alpha blockers
    Calcium channel blockers
    Renin inhibitors
    Vasodilators

    Segment by Application, the Antihypertensive market is segmented into
    Hosptial
    Clinic
    Home

    Regional and Country-level Analysis
    The Antihypertensive market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Antihypertensive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Antihypertensive Market Share Analysis
    Antihypertensive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antihypertensive business, the date to enter into the Antihypertensive market, Antihypertensive product introduction, recent developments, etc.

    The major vendors covered:
    Pfizer
    Novartis
    Sanofi
    Merck
    Boehringer Ingelheim
    Lupin
    Johnson & Johnson
    Astra Zeneca
    Daiichi Sankyo
    Ranbaxy

    Buy now